RMC
IMUX icon

Ring Mountain Capital’s Immunic IMUX Stock Holding History

Ring Mountain Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,804
Closed -$16K – 99
2025
Q3 		$16K Hold
1,804
– – 0.01% 99
2025
Q2 		$17.4K Hold
1,804
– – 0.01% 97
2025
Q1 		$19.7K Hold
1,804
– – 0.01% 90
2024
Q4 		$18K Buy
+1,804
New +$22.7K 0.01% 89

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ring Mountain Capital's IMUX Position: Q4 2025 in Review

Ring Mountain Capital sold out of Immunic (IMUX) in Q4 2025, closing a stake of 1,804 shares — an estimated $16K sold.

Ring Mountain Capital first reported a position in IMUX in Q4 2024 and held it in 4 quarters. The position peaked at $19.7K in Q1 2025. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2025.

  • Ring Mountain Capital reported no remaining Immunic position as of Q4 2025 after selling out during the quarter.
  • Ring Mountain Capital sold 1,804 Immunic shares in Q4 2025, an estimated $16K.
  • Ring Mountain Capital first reported a position in Immunic in Q4 2024 and held it in 4 quarters.
  • Ring Mountain Capital's Immunic position peaked at $19.7K in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2025.

Based on Ring Mountain Capital's 13F filing for Q4 2025, filed 27 Jan 2026.